These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1719636)

  • 1. Rusting of the lock and key model for protein-ligand binding.
    Jorgensen WL
    Science; 1991 Nov; 254(5034):954-5. PubMed ID: 1719636
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear magnetic resonance methods for studying protein-ligand complexes.
    Petros AM; Fesik SW
    Methods Enzymol; 1994; 239():717-39. PubMed ID: 7530321
    [No Abstract]   [Full Text] [Related]  

  • 3. Conformational polymorphism in peptidic and nonpeptidic drug molecules.
    Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD
    Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-induced conformation change of the immunosuppressant cyclosporin A.
    Wüthrich K; von Freyberg B; Weber C; Wider G; Traber R; Widmer H; Braun W
    Science; 1991 Nov; 254(5034):953-4. PubMed ID: 1948082
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunophilin structure: a template for immunosuppressive drug design?
    Walkinshaw MD; Kallen J; Weber HP; Widmer A; Widmer H; Zurini M
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):8-13. PubMed ID: 1496694
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural similarity of the binding sites of cyclophilin A-cyclosporin A and FKBP-FK506 systems.
    Denesyuk AI; Vihinen M; Lundell J; Zav'yalov VP; Korpela T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):912-7. PubMed ID: 7683466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR studies of [U-13C]cyclosporin A bound to human cyclophilin B.
    Neri P; Gemmecker G; Zydowsky LD; Walsh CT; Fesik SW
    FEBS Lett; 1991 Sep; 290(1-2):195-9. PubMed ID: 1915874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural studies of complexed FK-506 binding protein.
    Clardy J
    Ann N Y Acad Sci; 1993 Jun; 685():37-45. PubMed ID: 7689808
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural repeats in cyclosporin A.
    Denesyuk AI; Lundell J; Goldman A; Zav'yalov VP; Korpela T
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1438-42. PubMed ID: 8280162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential roles of other FK 506-binding proteins in mediating the effects of FK 506.
    Siekierka JJ; Wiederrecht G; Cryan J; Hung SH; Comisky M; Sigal NH
    Transplant Proc; 1991 Dec; 23(6):2720-1. PubMed ID: 1721256
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases.
    Kay JE
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolyl isomerase: enzymatic catalysis of slow protein-folding reactions.
    Schmid FX
    Annu Rev Biophys Biomol Struct; 1993; 22():123-42. PubMed ID: 7688608
    [No Abstract]   [Full Text] [Related]  

  • 15. The 3D structure of a cyclosporin analogue in water is nearly identical to the cyclophilin-bound cyclosporin conformation.
    Wenger RM; France J; Bovermann G; Walliser L; Widmer A; Widmer H
    FEBS Lett; 1994 Mar; 340(3):255-9. PubMed ID: 8131854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 17. Yeast cyclophilin-related gene encodes a nonessential second peptidyl-prolyl cis-trans isomerase associated with the secretory pathway.
    Tanida I; Yanagida M; Maki N; Yagi S; Namiyama F; Kobayashi T; Hayano T; Takahashi N; Suzuki M
    Transplant Proc; 1991 Dec; 23(6):2856-61. PubMed ID: 1721297
    [No Abstract]   [Full Text] [Related]  

  • 18. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of cyclosporin A and FK506.
    Bierer BE
    Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of enzymatic and nonenzymatic prolyl cis-trans isomerization.
    Stein RL
    Adv Protein Chem; 1993; 44():1-24. PubMed ID: 8317295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.